An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

2010 ◽  
Vol 82 (9) ◽  
pp. 1537-1544 ◽  
Author(s):  
Hidenori Toyoda ◽  
Takashi Kumada ◽  
Seiki Kiriyama ◽  
Makoto Tanikawa ◽  
Yasuhiro Hisanaga ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Interferon Alpha ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Viral Response ◽  
Standard Interferon ◽  
Early Viral Response ◽  
Peginterferon And Ribavirin ◽  
Hcv Genotype 1

scholarly journals Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting Therapy

Intervirology ◽  
2014 ◽  
Vol 57 (5) ◽  
pp. 289-296 ◽  
Author(s):  
Hidenori Toyoda ◽  
Takashi Kumada ◽  
Noritomo Shimada ◽  
Koichi Takaguchi ◽  
Tatsuya Ide ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Peginterferon And Ribavirin ◽  
Hcv Genotype 1

scholarly journals Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

JAMA ◽  
2015 ◽  
Vol 313 (17) ◽  
pp. 1728 ◽  
Author(s):  
Fred Poordad ◽  
William Sievert ◽  
Lindsay Mollison ◽  
Michael Bennett ◽  
Edmund Tse ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Dose Combination ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document